All subjects | Female subjects | Male subjects | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Group | No. of subjects (n) | DA (months) mean±SD | CA (months) mean±SD | DA-CA (months) mean±SD | No. of subjects (n) | DA (months) mean±SD | CA (months) mean±SD | DA-CA (months) mean±SD | No. of subjects (n) | DA (months) mean±SD | CA (months) mean±SD | DA-CA (months) mean±SD |
Group I | 238 | 115.9±7.7 | 122.9±3.3 | − 6.9±5.5 | 58 | 117.9±7.1 | 123.7±3.7 | − 5.9±4.5 | 180 | 115.3±7.9 | 122.6±3.1 | − 7.4±5.9 |
Group II | 95 | 134.2±4.8 | 136.5±2.9 | − 2.3±4.1 | 69 | 133.6±4.4 | 136.3±2.4 | − 2.7±4.2 | 26 | 135.9±5.6 | 137.1±3.9 | − 1.3±3.6 |
Group III | 126 | 148.8±5.1 | 149.4±3.7 | − 0.6±3.3 | 70 | 149.0±5.5 | 149.7±3.7 | − 0.7±3.4 | 56 | 148.7±4.6 | 149.1±3.7 | − 0.4±3.3 |
Group IV | 136 | 162.5±5.6 | 162.3±3.7 | 0.2±3.7 | 109 | 162.7±5.7 | 162.6±3.7 | 0.2±3.6 | 27 | 161.7±5.4 | 161.3±3.4 | 0.4±4.0 |
Group V | 98 | 172.5±5.8 | 173.1±3.6 | − 0.6±3.7 | 39 | 169.2±5.4 | 170.9±2.6 | − 1.7±4.0 | 59 | 174.7±4.6 | 174.6±3.4 | 0.1±3.6 |
Group VI | 207 | 189.9±6.7 | 188.1±3.9 | 1.8±4.1 | 97 | 190.9±2.9 | 189.5±2.4 | 1.4±2.4 | 110 | 189.1±8.8 | 186.9±4.5 | 2.2±5.3 |
Total | 900 | 152.7±28.5 | 154.4±24.9 | − 1.8±5.5 | 442 | 156.9±24.4 | 157.9±22.1 | − 1.1±4.2 | 458 | 148.6±31.5 | 151.1±27.0 | − 2.5±6.4 |